Many Humans are in a losing relationship with Cosmos Nature,..let alone their Earthly Nature.
~~Bottom line….Nature ALWAYS WINS folks!!
When it comes to Nature, don’t kid yourselves and/or ever go against Nature in any way, shape or form.
Which brings me to the dirty dealings of some that do…..the ones marketing and/or patenting synthetic forms/derivatives of the all~natural “Tree of Life”(Indian Hemp/Cannabis),…EW!!!( those of us who are awake know what I am talkin’ about,..if you are wakin’ up right now,….GoOod Marnin’ Sunshine!).
Ya see!!..Big Pharma certainly can’t be helping anyone at all by polluting desperate & sick Humans with unnatural types of pharmaceutical tra$h like this.
Nature’s Indian Hemp/Cannabis has been around a whole lot longer than the FDA & their gang of big crooked friends like at Big Pharma, in association with, but not limited to their so-called “inventors”….hmmmph….PLEASE!!! ,…more like whores of Babylon…they aren’t inventors, they are money bandits in lab coats, selling us out. They are committing genocide by marketing Cannabis derivatives and/or processing synthetics(ALL synthetics are poison & hazardous to the health of all living creatures/things),..synthetics are the worst of the worst. Synthetics are a HUGE threat to nature, PLEASE, don’t just “stand-by” until no Human is left to stand(by). Be Angel,..let your voices be heard(stray from the “herd”).
Which brings me to this: Why when a loved one gets diagnosed with MS for example(or how about cancer,…yup that f*#@!&%! scourge cancer),… why shouldn’t they be entitled to,…… whilst using their own free will, without anyones permission(doctors, ANY man-made laws/statutes or otherwise) to do what I have done, and research traditional medicines,..you know start from the early foundation, and beginnings of REAL MEDICINE,…ancient/traditional/natural medicines…..then follow the detours and many struggles of thee Cannabis Plant trying to save Humans,…and then many more detours hurdles and struggles for Humans who are ,..and/or have been awake, struggling to save other Humans,…AND a plant(Cannabis) that is restricted to grow freely as it did thousands of years ago.
We should be growing billions & billions & BILLIONS(gosh I LOVE Carl Sagan) of acres of cannabis on land all over thee World, for “BILLIONS “;-)’ of uses like for example: buildings, and building materials(tonnes of uses here alone folks), fuel(don’t get me started), fibre, food & medicine. As for food and medicine, well I prefer the ol’ y’know…natural medicine…..“Let food be thy medicine and medicine be thy food”~Hippocrates
Yet,the “powers that be”,(.. whilst using prohibition in combination with that bogus, & incorrect “schedule”) are hellbent on stopping the Human population from consuming natural cannabinoids,..even if it is to improve our health and prolong our life…. you should easily see the problem, if you are awake.
Meanwhile, this character Geoffery Guy (GW Pharmaceuticals) can legally grow at least 10,000 cannabis plants at each of his secret cannabis farms/factories,
He’s been granted permission,…. he is not considered a criminal??pffffttt ,..ask me,…I’ll tell you he sure as hell is!!!! He is aiding and abetting crooks @ Big Pharma, including their investments, marketing wizardry, and those dirty synthetic so called “legal” script-pushers and their cohort$.
Below you can see about 28 “patents”, “Applicants”,…and so called “inventors” of pharmaceutical cannabinoids to be used for diseases, disorders, and health problems, such as cancers(yes brain cancer too),epilepsy,pain,cancer pain,arthritis,neuropathic pain,neurodegeneration (example:alzheimer’s, “huntingdon’s,parkinson’s diseases”, multiple sclerosis, Downs syndrome, prion disease, palsy, spinal cord injury, or alcohol induced neurotoxicity ),nausea,vomiting,emesis,motion sickness or like conditions just to name a few.
~ Strange how God never gets any credit for HIS invention huh?
So by all means save your loved ones , save yourself, but don’t go against nature.
Don’t trust YOUR health into the pharmacy industry….they see you as their stock(…and I’ve seen/felt how they treat their “live” stocks).
Educate, grow your own, invest in a medicinal cannabis THC, CBD, CBN, etc Cannabinoid test-kit, consume massive amounts of healthy cannabinoids, then naturally….feel the HEAL in real Healthcare.~Truth
Patents…
…for cancer and cancer related pain.
~~~
|
Inventor:
PAROLARO DANIELA [IT] MASSI PAOLA [IT] (+21) |
Applicant:
GW PHARMA LTD [GB] OTSUKA PHARMA CO LTD [JP] (+1) |
|||||
Abstract of GB2478595 (A)
Translate this text into Tooltip
>
ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
|
|
One or more phytocannabinoids, selected from the group consisting of tetrahydrocannabivarin (THCV), cannabidivarin (CBDV), tetrahydrocannabivarinic acid, (THCVA), tetrahydrocannabinolic acid (THCA), cannabidiolic acid (CBDA), cannabidol (CBD), cannabigerol (CBG) and cannabichromene (CBC), are provided for use in the treatment of prostate cancer. Where present the THCVA is present in an isolated pytocannabinoid, the THCA, CBDA, CBD, CBG or CBC are present in the form of a BDS, and the THCV or CBDV are present in either an isolated form or in the form of a BDS. Alternatively, one or more phytocannabinoids or acid phytocannabinoids may be provided for use in the down regulation of ERK signaling and effect one or more of anti-proliferation, anti-metastasis or anti-angiogenesis in a human patient. Alternatively, one or more phytocannabinoid acid, excluding CBDA or CBDVA, may be provided, for use in medicine. Alternatively, a cannabis plant extract for use in medicine may comprise at least 50% w/w phytocannabinoid component, the non-phytocannabinoid component comprising a monoterpene fraction and a sesquiterpene fraction. Alternatively, an isolated CBD and/or CBD BDS may be provided for use in the treatment of a pre-cancerous symptom of colon cancer. Alternatively, a combination of phytocannabinoids together with a chemotherapeutic agent may be provided for use in the treatment of a glioma.
~~~
|
Inventor: DIEZ GUILLERMO VELASCO [ES] PASTOR MANUEL GUZMAN [ES] (+3) |
Applicant: GW PHARMA LTD [GB] OTSUKA PHARMA CO LTD [JP] |
|||||
Abstract of GB2478072 (A)
Translate this text into Tooltip
>
ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
|
|
A combination of cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD). for use in the treatment of a brain tumour, the compounds being in a ratio of the compounds are in the ratio of 5:1 to 1:5. The brain tumour may be a glioma/glioblastoma. The cannabinoids may be present as plant extracts and may be administered separately, sequentially or simultaneously.
~~~
|
Inventor: WHITTLE BRIAN [GB] PAROLARO DANIELA [IT] |
Applicant: GW PHARMA LTD [GB] |
|||||
Abstract of US2012225136 (A1)
Translate this text into Tooltip
>
ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
|
|
The invention relates to the use of a cannabis plant extract or a cannabinoid as a pharmaceutically active agent in the inhibition of tumour cell migration.
~~~
|
Inventor: DIEZ GUILLERMO VELASCO [ES] PASTOR MANUEL GUZMAN [ES] (+3) |
Applicant: GW PHARMA LTD [GB] OTSUKA PHARMA CO LTD [JP] |
|||||
Abstract of GB2478074 (A)
Translate this text into Tooltip
>
ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
|
|
A combination of cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD). for use in the treatment of a tumour, to reduce cell viability, inhibit cell growth or reduce tumour volume. Preferably the tumour is a brain tumour, more specifically a glioma or glioblastoma. Preferably the compounds are in the ratio of 5:1 to 1:5. The cannabinoids may be present as plant extracts and may be administered separately, sequentially or simultaneously.
~~~
|
Inventor: GUY GEOFFREY [GB] ROBSON PHILIP [GB] |
Applicant: GW PHARMA LTD [GB] |
|||||
Abstract of US2011230549 (A1)
Translate this text into Tooltip
>
ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
|
|
The present invention relates to treatment of cancer related pain and constipation. Preferably the subject in need is administered a combination of the cannabinoids cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC). More preferably the cannabinoids are in a predefined ratio by weight of approximately 1:1 of CBD to THC.
~~~
|
Inventor: PAROLARO DANIELA [GB] MASSI PAOLA [GB] (+21) |
Applicant: GW PHARMA LTD [GB] OTSUKA PHARMA CO LTD [JP] |
|||||
Abstract not available for AR080454 (A1)
Abstract of corresponding document: GB2478595 (A)
Translate this text into Tooltip
>
Select language
|
|
One or more phytocannabinoids, selected from the group consisting of tetrahydrocannabivarin (THCV), cannabidivarin (CBDV), tetrahydrocannabivarinic acid, (THCVA), tetrahydrocannabinolic acid (THCA), cannabidiolic acid (CBDA), cannabidol (CBD), cannabigerol (CBG) and cannabichromene (CBC), are provided for use in the treatment of prostate cancer. Where present the THCVA is present in an isolated pytocannabinoid, the THCA, CBDA, CBD, CBG or CBC are present in the form of a BDS, and the THCV or CBDV are present in either an isolated form or in the form of a BDS. Alternatively, one or more phytocannabinoids or acid phytocannabinoids may be provided for use in the down regulation of ERK signaling and effect one or more of anti-proliferation, anti-metastasis or anti-angiogenesis in a human patient. Alternatively, one or more phytocannabinoid acid, excluding CBDA or CBDVA, may be provided, for use in medicine. Alternatively, a cannabis plant extract for use in medicine may comprise at least 50% w/w phytocannabinoid component, the non-phytocannabinoid component comprising a monoterpene fraction and a sesquiterpene fraction. Alternatively, an isolated CBD and/or CBD BDS may be provided for use in the treatment of a pre-cancerous symptom of colon cancer. Alternatively, a combination of phytocannabinoids together with a chemotherapeutic agent may be provided for use in the treatment of a glioma.
~~~
|
Cancer medication using cannabinoids in combination with non-cannabinoids |
||||||
|
Inventor: VELASCO DIEZ GUILLERMO [ES] GUZMAN PASTOR MANUEL [ES] (+2) |
Applicant: GW PHARMA LTD [GB] OTSUKA PHARMA CO LTD [JP] |
|||||
Abstract not available for CO6341551 (A2)
Abstract of corresponding document: GB2460672 (A)
Translate this text into Tooltip
>
Select language
|
|
The invention relates to the use of one or more cannabinoids, particularly tetrahydrocannabinol (THC) and/or cannabidiol (CBD) in combination with a non-cannabinoid chemotherapeutic agent in the manufacture of a medicament for use in the treatment of cancer. In particular the cancer to be treated is a brain tumour, more particularly a glioma, more particularly still a glioblastoma multiforme (G B M). The non-cannabinoid chemotherapeutic agent maybe a selective estrogen receptor modulator (SERM) or an alkylating agent.
~~~
|
Inventor: VELASCO DIEZ GUILLERMO [ES] GUZMAN PASTOR MANUEL [ES] (+3) |
Applicant: GW PHARMA LTD [GB] OTSUKA PHARMA CO LTD [JP] |
|||||
Abstract not available for CO6382172 (A2)
Abstract of corresponding document: WO2009147439 (A1)
Translate this text into Tooltip
>
Select language
|
|
The invention relates to the use of a combination of cannabinoids, particularly tetrahydrocannabinol (THC) and cannabidiol (CBD), in the manufacture of a medicament for use in the treatment of cancer. In particular the cancer to be treated is a brain tumour, more particularly a glioma, more particularly still a glioblastoma multiforme (GBM).
~~~
…for Epilepsy
|
Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy |
||||||
|
Inventor: WHALLEY BENJAMIN [GB] WILLIAMS CLAIRE [GB] (+2) |
Applicant: GW PHARMA LTD [GB] OTSUKA PHARMA CO LTD [JP] (+1) |
|||||
Abstract of GB2479153 (A)
Translate this text into Tooltip
>
ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
|
|
The invention relates to the use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy, in particular epilepsy characterised by generalised seizures. CBDV may be used in an isolated form or as a botanical drug substance. Preferably, CBDV is used with one or more therapeutically effective phytocannabinoids such as tetrahydrocannabivarin (THCV) and cannabidiol (CBD), and in combination with a standard anti-epileptic drug, Also claimed is a cannabis plant extract for use in the treatment of epilepsy, the extract containing at least 50 wt% of a phytocannabinoid fraction including CBDV as principal phytocannabinoid and CBD as secondary phytocannabinoid, and a non-phytocannabinoid fraction including monoterpenes and sesquitelpenes. Preferably the cannabis plant extract further comprises THCV. Some of the examples relate only to the use of THCV or CBD in models of epilepsy.
~~~
|
USE OF ONE OR A COMBINATION OF PHYTO-CANNABINOIDS IN THE TREATMENT OF EPILEPSY |
||||||
|
Inventor: WHALLEY BEN [GB] STEPHENS GARY [GB] (+4) |
Applicant: GW PHARMA LTD [GB] OTSUKA PHARMA CO LTD [JP] |
|||||
Abstract of CA2766082 (A1)
Translate this text into Tooltip
>
ChineseDanishDutchFinnishFrenchGermanGreekHungarianItalianNorwegianPolishPortugueseSpanishSwedish
|
|
This invention relates to the use of one or more cannabinoids in the treatment of epilepsy and more particularly to the use of one or a combination of cannabinoids in the treatment of generalized or partial seizure. In one embodiment it relates to the use of the cannabinoid THCV, as a pure or isolated compound, or as a plant extract in which significant amounts of any THC naturally present has been selectively removed. In another embodiment the phytocannabinoid is CBD.
~~~
Continue by reading full article please.
